Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation

被引:153
作者
Fragale, A
Tartaglia, M
Wu, J
Gelb, BD
机构
[1] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Dept Human Genet, New York, NY USA
[3] Ist Super Sanita, Virol Lab, I-00161 Rome, Italy
[4] Ist Super Sanita, Lab Metab & Biochim Patol, I-00161 Rome, Italy
[5] H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL USA
关键词
PTPN11; SHP2; SHP-2; Noonan syndrome; NS; signal transduction; mitogen-activated protein kinase; epidermal growth factor; GAB1; ERK2; MAPK1;
D O I
10.1002/humu.20005
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Noonan syndrome is a developmental disorder with dysmorphic facies, short stature, cardiac defects, and skeletal anomalies, which can be caused by missense PTPN11 mutations. PTPN11 encodes Src homology 2 domain-containing tyrosine phosphatase 2 (SHP2 or SHR-2), a protein tyrosine phosphatase that acts in signal transduction downstream to growth factor, hormone, and cytokine receptors. We compared the functional effects of three Noonan syndrome-causative PTPN11 mutations on SHP2's phosphatase activity, interaction with a binding partner, and signal transduction. All SHP2 mutants had significantly increased basal phosphatase activity compared to wild type, but that activity varied significantly between mutants and was further increased after epidermal growth factor stimulation. Cells expressing SHP2 mutants had prolonged extracellular signal-regulated kinase 2 activation, which was ligand-dependent. Binding of SHP2 mutants to Grb2-associated binder-1 was increased and sustained, and tyrosine phosphorylation of both proteins was prolonged. Coexpression of Grb2 associated binder-1-FF, which lacks SHP2 binding motifs, blocked the epidermal growth factor,mediated increase in SHP2's phosphatase activity and resulted in a dramatic reduction of extracellular signal,regulated kinase 2 activation. Taken together, these results document that Noonan syndrome-associated PTPN11 mutations increase SHP2's basal phosphatase activity, with greater activation when residues directly involved in binding at the interface between the N-terminal Src homology 2 and protein tyrosine phosphatase domains are altered. The SHP2 mutants prolonged signal flux through the RAS/mitogen-activated protein kinase (ERK2/MAPK1) pathway in a ligand, dependent manner that required docking through Grb2-associated binder-1 (GAB1), leading to increased cell proliferation. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:267 / 277
页数:11
相关论文
共 50 条
  • [31] Requirement of Shp-2 tyrosine phosphatase in lymphoid and hematopoietic cell development
    Qu, CK
    Nguyen, S
    Chen, JZ
    Feng, GS
    [J]. BLOOD, 2001, 97 (04) : 911 - 914
  • [32] THE PHOSPHOTYROSINE PHOSPHATASE PTP1D, BUT NOT PTP1C, IS AN ESSENTIAL MEDIATOR OF FIBROBLAST PROLIFERATION INDUCED BY TYROSINE KINASE AND G-PROTEIN-COUPLED RECEPTORS
    RIVARD, N
    MCKENZIE, FR
    BRONDELLO, JM
    POUYSSEGUR, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (18) : 11017 - 11024
  • [33] Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.0.CO
  • [34] 2-6
  • [35] Mutagenesis reveals a role for epidermal growth factor receptor extracellular subdomain TV in ligand binding
    Saxon, ML
    Lee, DC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (40) : 28356 - 28362
  • [36] The SH2 tyrosine phosphatase Shp2 is required for mammalian limb development
    Saxton, TM
    Ciruna, BG
    Holmyard, D
    Kulkarni, S
    Harpal, K
    Rossant, J
    Pawson, T
    [J]. NATURE GENETICS, 2000, 24 (04) : 420 - 423
  • [37] Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2
    Saxton, TM
    Henkemeyer, M
    Gasca, S
    Shen, R
    Rossi, DJ
    Shalaby, F
    Feng, GS
    Pawson, T
    [J]. EMBO JOURNAL, 1997, 16 (09) : 2352 - 2364
  • [38] PTPN11 mutation in a large family with Noonan syndrome and dizygous twinning
    Schollen, E
    Matthijs, G
    Gewillig, M
    Fryns, JP
    Legius, E
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2003, 11 (01) : 85 - 88
  • [39] Shi YB, 1998, INT J MOL MED, V2, P273
  • [40] Molecular mechanism for the Shp-2 tyrosine phosphatase function in promoting growth factor stimulation of Erk activity
    Shi, ZQ
    Yu, DH
    Park, M
    Marshall, M
    Feng, GS
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (05) : 1526 - 1536